Tirzepatide is a New Medication for Diabetes and Weight Loss Tirzepatide (Mounjaro) is known as a dual incretin agonist or a twincreatin because it works on the receptors for 2 hunger hormones GIP and GLP-1
Athletic overtraining
Rybelsus typically requires failing injectable GLP-1s first, an ironic requirement given that many patients specifically want to avoid injections
When metformin is contraindicated or not tolerated in patients with diabetes and CKD, several alternative agents are available, though selection requires careful consideration of kidney function, cardiovascular comorbidities, and individual patient factors
Your overall dietary foundation on semaglutide should follow a simple hierarchy: protein first, fiber second, healthy fats third, and complex carbohydrates last
There is no FDA approval for use in patients under 18 years of age at this time